These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
908 related items for PubMed ID: 15183475
1. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing? Levendag P, Nijdam W, Noever I, Schmitz P, van de Pol M, Sipkema D, Braat C, de Boer M, Jansen P. Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):713-24. PubMed ID: 15183475 [Abstract] [Full Text] [Related]
2. Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate. Nijdam W, Levendag P, Noever I, Uyl-de Groot C, van Agthoven M. Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):488-94. PubMed ID: 15145167 [Abstract] [Full Text] [Related]
3. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch]. Mazeron JJ, Belkacemi Y, Simon JM, Le Péchoux C, Martin M, Haddad E, Piedbois P, Calitchi E, Strunski W, Peynègre R, Le Bourgeois JP, Pierquin B. Bull Cancer Radiother; 1996 Jun 01; 83(1):47-53. PubMed ID: 8679281 [Abstract] [Full Text] [Related]
4. Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue. van de Pol M, Levendag PC, de Bree RR, Franssen JH, Smeele LE, Nijdam WM, Jansen PP, Meeuwis CA, Leemans CR. Brachytherapy; 2004 Jun 01; 3(2):78-86. PubMed ID: 15374539 [Abstract] [Full Text] [Related]
5. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT. Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1440-50. PubMed ID: 15590175 [Abstract] [Full Text] [Related]
6. [Value of the combination of external radiotherapy and curietherapy in carcinoma of the velo-tonsillar region. Statistical study of a series of 361 patients]. Pernot M, Hoffstetter S, Malissard L, Luporsi E, Peiffert D, Aletti P, Marchal C, Kozminski P, Bey P. Bull Cancer Radiother; 1996 Dec 01; 83(1):40-6. PubMed ID: 8679280 [Abstract] [Full Text] [Related]
7. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma. Zheng XK, Chen LH, Chen YQ, Deng XG. Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):165-70. PubMed ID: 15337552 [Abstract] [Full Text] [Related]
8. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy. Andrews SF, Anderson PR, Eisenberg BL, Hanlon AL, Pollack A. Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):475-80. PubMed ID: 15145165 [Abstract] [Full Text] [Related]
9. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma. Takácsi-Nagy Z, Polgár C, Oberna F, Somogyi A, Major T, Remenár E, Fodor J, Kásler M, Németh G. Strahlenther Onkol; 2004 Dec 01; 180(12):768-75. PubMed ID: 15592696 [Abstract] [Full Text] [Related]
10. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach. Rusthoven KE, Raben D, Schneider C, Witt R, Sammons S, Raben A. Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1365-70. PubMed ID: 19168295 [Abstract] [Full Text] [Related]
11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H. Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838 [Abstract] [Full Text] [Related]
12. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Chao KS, Ozyigit G, Blanco AI, Thorstad WL, Deasy JO, Haughey BH, Spector GJ, Sessions DG. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):43-50. PubMed ID: 15093897 [Abstract] [Full Text] [Related]
13. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis. Takácsi-Nagy Z, Oberna F, Polgár C, Somogyi A, Major T, Németh G. Neoplasma; 2001 May 01; 48(1):76-81. PubMed ID: 11327543 [Abstract] [Full Text] [Related]
14. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer. Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE. Head Neck; 2004 Jul 01; 26(7):561-72. PubMed ID: 15229898 [Abstract] [Full Text] [Related]
16. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Karakoyun-Celik O, Norris CM, Tishler R, Mahadevan A, Clark JR, Goldberg S, Devlin P, Busse PM. Head Neck; 2005 May 01; 27(5):353-61. PubMed ID: 15726587 [Abstract] [Full Text] [Related]
17. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results. Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E. Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569 [Abstract] [Full Text] [Related]
18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
19. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity. Alektiar KM, Brennan MF, Singer S. Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):202-8. PubMed ID: 16111590 [Abstract] [Full Text] [Related]
20. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series. Ferrigno R, Nishimoto IN, Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV. Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1108-16. PubMed ID: 15990016 [Abstract] [Full Text] [Related] Page: [Next] [New Search]